| Literature DB >> 28434781 |
Arun K Ghosh1, Margherita Brindisi2, Prasanth R Nyalapatla2, Jun Takayama2, Jean-Rene Ella-Menye2, Sofiya Yashchuk2, Johnson Agniswamy3, Yuan-Fang Wang3, Manabu Aoki4, Masayuki Amano4, Irene T Weber5, Hiroaki Mitsuya6.
Abstract
Based upon molecular insights from the X-ray structures of inhibitor-bound HIV-1 protease complexes, we have designed a series of isophthalamide-derived inhibitors incorporating substituted pyrrolidines, piperidines and thiazolidines as P2-P3 ligands for specific interactions in the S2-S3 extended site. Compound 4b has shown an enzyme Ki of 0.025nM and antiviral IC50 of 69nM. An X-ray crystal structure of inhibitor 4b-HIV-1 protease complex was determined at 1.33Å resolution. We have also determined X-ray structure of 3b-bound HIV-1 protease at 1.27Å resolution. These structures revealed important molecular insight into the inhibitor-HIV-1 protease interactions in the active site.Entities:
Keywords: Drug-resistance; HIV-1 protease; Isophthalamide; Synthesis; X-ray structure
Mesh:
Substances:
Year: 2017 PMID: 28434781 PMCID: PMC5617771 DOI: 10.1016/j.bmc.2017.04.005
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641